M. Kamberi

发表

Regulation of bronchoalveolar macrophage proinflammatory cytokine production by dexamethasone and granulocyte-macrophage colony-stimulating factor after stimulation by Aspergillus conidia or lipopolysaccharide.

M. Kamberi, E. Brummer, D. Stevens, 2002, Cytokine.

Setting acceptance criteria for validation of analytical methods of drug eluting stents: Minimum requirements for analytical variability.

R. Rapoza, M. Kamberi, H. Garcia, 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

UV-visible spectroscopy as an alternative to liquid chromatography for determination of everolimus in surfactant-containing dissolution media: a useful approach based on solid-phase extraction.

M. Kamberi, Thu-Ngoc Tran, 2012, Journal of pharmaceutical and biomedical analysis.

A High Throughput Method for Determination of Hydrophobic Drugs in Surfacant-Containing Dissolution Media Used to Evaluate In-Vitro Release of Drug Eluting Stents ( DES )

M. Kamberi, Thu-Ngoc Tran, 2013 .

A sensitive high-throughput HPLC assay for simultaneous determination of everolimus and clobetasol propionate.

M. Kamberi, Katherine Fu, Debra Feder, 2008, Journal of chromatographic science.

Analysis of non-covalent aggregation of synthetic hPTH (1-34) by size-exclusion chromatography and the importance of suppression of non-specific interactions for a precise quantitation.

Zengji Li, M. Kamberi, S. Fields, 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Quantification of apolipoprotein A-I mimetic peptide D-4F in rabbit plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.

M. Kamberi, Xiaoyi Hu, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

A novel accelerated in vitro release method for biodegradable coating of drug eluting stents: Insight to the drug release mechanisms.

M. Kamberi, Debra Feder, Sushma Nayak, 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Regulation by granulocyte-macrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia.

M. Kamberi, E. Brummer, D. Stevens, 2003, The Journal of infectious diseases.

Influences of Urinary pH on Ciprofloxacin Pharmacokinetics in Humans and Antimicrobial Activity In Vitro versus Those of Sparfloxacin

M. Kamberi, Y. Niki, T. Kotegawa, 1999, Antimicrobial Agents and Chemotherapy.

Chemical Characterization of Leachables in Catheter Device

M. Kamberi, Jie Hu, Haibo Wang, 2022, ACS omega.

A validated, sensitive HPLC method for the determination of trace impurities in acetaminophen drug substance.

M. Kamberi, C. Riley, Xiaoyan Ma Sharon, 2004, Journal of pharmaceutical and biomedical analysis.

Long-Term Safety of an Everolimus-Eluting Bioresorbable Vascular Scaffold and the Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

R. Virmani, F. Otsuka, F. Kolodgie, 2014, Circulation. Cardiovascular interventions.

Stability testing of drug eluting stents

Marika Kamberi, Richard Rapoza, R. Rapoza, 2016 .

Evaluation of chemical stability of polymers of XIENCE everolimus-eluting coronary stents in vivo by pyrolysis-gas chromatography/mass spectrometry.

R. Virmani, F. Kolodgie, R. Rapoza, 2018, Journal of biomedical materials research. Part B, Applied biomaterials.

Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model

J. Reiber, P. Serruys, H. Garcia-Garcia, 2015, The International Journal of Cardiovascular Imaging.

Determination of ciprofloxacin in plasma and urine by HPLC with ultraviolet detection.

M. Kamberi, K. Nakamura, T. Kotegawa, 1998, Clinical chemistry.